Miró, L.; López, J.; Guerrero, P.E.; MartÃnez-Bosch, N.; Manero-Rupérez, N.; Moreno, M.; Ortiz, M.R.; Llop, E.; Navarro, P.; Peracaula, R.
Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice. Cancers 2022, 14, 6133.
https://doi.org/10.3390/cancers14246133
AMA Style
Miró L, López J, Guerrero PE, MartÃnez-Bosch N, Manero-Rupérez N, Moreno M, Ortiz MR, Llop E, Navarro P, Peracaula R.
Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice. Cancers. 2022; 14(24):6133.
https://doi.org/10.3390/cancers14246133
Chicago/Turabian Style
Miró, Laura, Júlia López, Pedro E. Guerrero, Neus MartÃnez-Bosch, Noemà Manero-Rupérez, Mireia Moreno, M. Rosa Ortiz, Esther Llop, Pilar Navarro, and Rosa Peracaula.
2022. "Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice" Cancers 14, no. 24: 6133.
https://doi.org/10.3390/cancers14246133
APA Style
Miró, L., López, J., Guerrero, P. E., MartÃnez-Bosch, N., Manero-Rupérez, N., Moreno, M., Ortiz, M. R., Llop, E., Navarro, P., & Peracaula, R.
(2022). Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice. Cancers, 14(24), 6133.
https://doi.org/10.3390/cancers14246133